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INTRODUCTION

Severe hypoglycemia (BG ≤40)

• Determine intraop monitoring and treatment
practices of diabetic patients at a large
academic hospital

Figure 3. Patient who took normal insulin dose while NPO
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• After IRB approval, diabetic patients who had
surgery from 2005-2010 were retrospectively
analyzed (Table 1)
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Figure 1. Insulin use by preoperative insulin status
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• Evaluate possible causes of hypoglycemia
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• Determine the incidence of intraoperative
hypoglycemia and severe hypoglycemia
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• We performed this retrospective, observational
analysis to:

Description
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• Anesthesia masks signs and symptoms of
hypoglycemia, making intraop hypoglycemia
difficult to detect clinically

Table 1. Hypoglycemia incidence
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• Although studies are conflicting as to the benefit
of intensive insulin therapy (IIT) in the critically
ill,1,2,3 there is a 6x increase in hypoglycemia
incidence in patients treated with IIT4

RESULTS

Figure 2. Failure to check hourly BG while on insulin infusion
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Figures 2 and 3

• dextrose (D50) doses given
• Data obtained from our Anesthesia Information
Management System and point-of-care glucose
(Accu-Chek) databases
• Manual chart examination and root cause
analysis for patients with BG <40
• Patients receiving insulin and D50 for
hyperkalemia were excluded
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DISCUSSION
• Despite conservative glycemic practices, clinically relevant intraoperative
hypoglycemia still occurred in 115 (1.05%) of diabetic patients (95% CI 0.87 – 1.26 %
by Clopper-Pearson)
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• Hypoglycemia incidence similar to that in conventional tx group in ICU studies1,3
• Frequent monitoring of BG during administration of IV insulin is mandatory

• Insulin treatment as a function of highest intraop
glucose was determined (Fig 1)

• Differences in treatment thresholds between patients on and not on pre-op insulin
may reflect a reticence to institute a new treatment modality in insulin-naïve patients

• Representative examples of 2 patients who
experienced severe intraop hypoglycemia are
presented graphically (Figs 2 and 3)

• Explanations for severe hypoglycemic events include taking insulin while NPO,
excessive insulin administration, and not checking hourly BG while on an insulin
infusion
• Most episodes of severe hypoglycemia were likely preventable
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